Source link : https://www.newshealth.biz/health-news/lpa1-receptor-affects-biomarkers-in-pulmonary-fibrosis/
VIENNA — Treatment with a novel lysophosphatidic acid receptor 1 (LPA1) antagonist was associated with significant changes in baseline biomarkers of disease in adults with pulmonary fibrosis, based on data from more than 300 individuals. “Lysophosphatidic acid receptor signaling is central to the pathogenesis of fibrotic lung diseases,” said Toby M. Maher, MD, of the […]
Author : News Health
Publish date : 2024-09-16 12:56:44
Copyright for syndicated content belongs to the linked Source.
in Health